Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60,950 | 35 | 70.4% |
| Food and Beverage | $16,448 | 891 | 19.0% |
| Travel and Lodging | $5,049 | 45 | 5.8% |
| Consulting Fee | $4,100 | 3 | 4.7% |
| Education | $49.45 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $21,184 | 160 | $0 (2024) |
| Amarin Pharma Inc. | $20,441 | 60 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16,654 | 94 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $9,468 | 49 | $0 (2020) |
| Lilly USA, LLC | $6,926 | 147 | $0 (2024) |
| Esperion Therapeutics, Inc. | $4,211 | 33 | $0 (2024) |
| Novo Nordisk Inc | $1,479 | 92 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,001 | 61 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $544.87 | 4 | $0 (2019) |
| Corcept Therapeutics | $534.31 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,954 | 113 | Lilly USA, LLC ($504.90) |
| 2023 | $1,618 | 81 | Lilly USA, LLC ($713.51) |
| 2022 | $1,728 | 95 | Lilly USA, LLC ($494.81) |
| 2021 | $3,581 | 111 | AbbVie Inc. ($1,987) |
| 2020 | $7,675 | 98 | Esperion Therapeutics, Inc. ($3,864) |
| 2019 | $16,877 | 147 | Amarin Pharma Inc. ($11,291) |
| 2018 | $22,087 | 181 | Amarin Pharma Inc. ($9,001) |
| 2017 | $31,078 | 155 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,711) |
All Payment Transactions
981 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $32.72 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/31/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/28/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes Care | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Diabetes Care | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: Diabetes Care | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $26.33 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardio-renal | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes Care | ||||||
| 09/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 530 | 1,137 | $108,693 | $46,063 |
| 2022 | 6 | 564 | 1,052 | $122,303 | $54,815 |
| 2021 | 7 | 707 | 1,426 | $136,019 | $64,380 |
| 2020 | 7 | 631 | 1,285 | $126,992 | $51,594 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 380 | $66,505 | $30,858 | 46.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 54 | $12,700 | $5,619 | 44.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 120 | 315 | $12,480 | $2,975 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $7,000 | $2,839 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 56 | $6,720 | $2,514 | 37.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 24 | $1,560 | $630.52 | 40.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 120 | 288 | $1,728 | $628.11 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 386 | $64,380 | $30,143 | 46.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 104 | 149 | $33,825 | $17,485 | 51.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 150 | 353 | $13,990 | $3,380 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $8,550 | $3,089 | 36.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 17 | 18 | $810.00 | $455.16 | 56.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 92 | 120 | $748.00 | $262.74 | 35.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 409 | $67,485 | $32,945 | 48.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 108 | 154 | $34,650 | $18,492 | 53.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 36 | 36 | $11,700 | $5,557 | 47.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 168 | 427 | $15,150 | $4,146 | 27.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 50 | 55 | $3,250 | $1,349 | 41.5% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 16 | 31 | $1,900 | $1,185 | 62.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 140 | 314 | $1,884 | $706.50 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 202 | 482 | $79,530 | $32,488 | 40.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 85 | 105 | $23,625 | $10,137 | 42.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 163 | 383 | $11,490 | $3,690 | 32.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 25 | 25 | $8,095 | $3,484 | 43.0% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 12 | 22 | $2,380 | $1,008 | 42.3% |
About Dr. Philip Ryan, MD
Dr. Philip Ryan, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Martinsburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043396229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Ryan, MD has received a total of $86,596 in payments from pharmaceutical and medical device companies, with $1,954 received in 2024. These payments were reported across 981 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($60,950).
As a Medicare-enrolled provider, Ryan has provided services to 2,432 Medicare beneficiaries, totaling 4,900 services with total Medicare billing of $216,852. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Martinsburg, WV
- Active Since 10/31/2006
- Last Updated 02/07/2012
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1043396229
Products in Payments
- JARDIANCE (Drug) $20,976
- Vascepa (Drug) $20,441
- Synthroid (Drug) $15,660
- FARXIGA (Drug) $9,450
- NEXLIZET (Drug) $3,795
- SYNTHROID (Drug) $3,223
- Ozempic (Drug) $1,013
- MOUNJARO (Drug) $813.90
- TRADJENTA (Drug) $733.40
- t-slim insulin pump (Device) $544.87
- Korlym (Drug) $534.31
- TRULICITY (Drug) $528.80
- NEXLETOL (Drug) $415.67
- Kerendia (Drug) $395.44
- TOUJEO (Drug) $337.22
- Repatha (Biological) $335.23
- Androgel (Drug) $320.82
- INVOKANA (Drug) $298.02
- FREESTYLE LIBRE 3 (Device) $268.86
- BAQSIMI (Drug) $261.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Martinsburg
Zachary Kistka, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $215,984
Sheila Ramirez-Rodriguez, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,068
Emma Morton-Eggleston, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $187.66